Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

2(66.7%)

Phase 1

1(33.3%)

3Total

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07139899Recruiting

Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma

Role: collaborator

NCT06271408Phase 1Recruiting

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Role: lead

NCT03417687Phase 3Completed

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection

Role: lead

NCT03418090Phase 3Completed

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant

Role: lead

All 4 trials loaded